Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer
Thomas Hatschek,Theodoros Foukakis,Judith Bjöhle,Tobias Lekberg,Hanna Fredholm,Ellinor Elinder,Ana Bosch,Gyula Pekar,Henrik Lindman,Aglaia Schiza,Zakaria Einbeigi,Jamila Adra,Anne Andersson,Lena Carlsson,Ann Charlotte Dreifaldt,Erika Isaksson-Friman,Susanne Agartz,Edward Azavedo,Per Grybäck,Mats Hellström,Hemming Johansson,Claudia Maes,Ioannis Zerdes,Johan Hartman,Yvonne Brandberg,Jonas Bergh JAMA Oncology(2021)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper